• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服抗凝剂剂量计算及预约安排算法的验证

Validation of an algorithm for oral anticoagulant dosing and appointment scheduling.

作者信息

Vadher B D, Patterson D L, Leaning M S

机构信息

Department of Cardiology, Whittington Hospital Highgate Hill, London, UK.

出版信息

Clin Lab Haematol. 1995 Dec;17(4):339-45.

PMID:8697730
Abstract

Computer clinical decision-support systems require validation before clinical use. This study compared recommendations on warfarin dosage adjustment and timing of the next appointment made by an algorithm with those made by experienced and inexperienced clinicians. Data abstracted from the records of 125 patients seen regularly in the anticoagulant clinic were used. The algorithm recommended dose changes and next appointment for cases with INRs between 1.8 to 4.2 (therapeutic range 2.0-3.0) and between 2.3 to 5.3 (therapeutic range 3.0-4.5). Beyond these values the algorithm referred the cases to "see doctor'. Compared to experienced clinicians, the algorithm was better at "recognising' difficult patients than inexperienced clinicians (kappa = 0.43 and 0.32 respectively). There was no statistically significant difference between all decision makers in dosage recommendations for the non-difficult cases, but there was much more variation amongst the inexperienced clinicians. The interval recommendations were statistically different between and within the different decision-makers. The inexperienced clinicians tended to give relatively longer intervals for a given dose change. In conclusion, the algorithm performs better than inexperienced clinicians and as well as experienced clinicians for the non-difficult cases.

摘要

计算机临床决策支持系统在临床应用前需要进行验证。本研究比较了一种算法给出的华法林剂量调整建议和下次预约时间与经验丰富和经验不足的临床医生给出的建议。使用了从抗凝门诊定期就诊的125例患者的记录中提取的数据。该算法针对国际标准化比值(INR)在1.8至4.2(治疗范围2.0 - 3.0)以及2.3至5.3(治疗范围3.0 - 4.5)之间的病例推荐剂量变化和下次预约时间。超出这些值时,算法会将病例转诊至“看医生”。与经验丰富的临床医生相比,该算法在“识别”困难患者方面比经验不足的临床医生表现更好(kappa值分别为0.43和0.32)。对于非困难病例,所有决策者在剂量推荐方面没有统计学上的显著差异,但经验不足的临床医生之间的差异更大。不同决策者之间以及同一决策者内部的间隔建议在统计学上存在差异。对于给定的剂量变化,经验不足的临床医生倾向于给出相对更长的间隔时间。总之,对于非困难病例,该算法的表现优于经验不足的临床医生,且与经验丰富的临床医生相当。

相似文献

1
Validation of an algorithm for oral anticoagulant dosing and appointment scheduling.口服抗凝剂剂量计算及预约安排算法的验证
Clin Lab Haematol. 1995 Dec;17(4):339-45.
2
Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.口服抗凝剂的起始治疗:使用华法林剂量计算图的理论依据。
Semin Vasc Med. 2003 Aug;3(3):255-60. doi: 10.1055/s-2003-44461.
3
Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment).计算机辅助管理对抗凝治疗患者治疗质量的影响:APROAT(口服抗凝治疗自动化程序)的一项前瞻性、随机、多中心试验。
Haematologica. 2001 Oct;86(10):1060-70.
4
Optimal initial dose adjustment of warfarin in orthopedic patients.骨科患者华法林的最佳初始剂量调整
Ann Pharmacother. 2007 Nov;41(11):1798-804. doi: 10.1345/aph.1K197. Epub 2007 Oct 2.
5
Development of a MUMPS-based anticoagulant management system.基于腮腺炎的抗凝管理系统的开发。
Br J Biomed Sci. 1993 Jun;50(2):117-24.
6
Knowledge base of clinicians regarding oral anticoagulant therapy in a teaching institution--a questionnaire survey.
J Assoc Physicians India. 2004 Nov;52:868-72.
7
Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.在城市周边贫困人群中,人工心脏瓣膜患者使用固定剂量与调整剂量华法林的比较。
J Heart Valve Dis. 2002 Jul;11(4):583-92; discussion 593.
8
A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program.DAWN AC计算机辅助口服抗凝剂剂量方案的多中心随机评估。
Thromb Haemost. 2009 Mar;101(3):487-94.
9
Will a once-weekly anticoagulant for the treatment and secondary prevention of thromboembolism improve adherence?一种用于血栓栓塞治疗和二级预防的每周一次抗凝剂能否提高依从性?
Thromb Haemost. 2009 Mar;101(3):422-7.
10
CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy.口服抗凝治疗诱导期的CYP2C9基因型与剂量需求
Clin Pharmacol Ther. 2004 Mar;75(3):198-203. doi: 10.1016/j.clpt.2003.09.015.

引用本文的文献

1
Warfarin Pharmacogenetics: New Life for an Old Drug.华法林药物遗传学:一种老药的新生命
Acta Cardiol Sin. 2013 May;29(3):235-42.
2
Pharmacogenetics of warfarin: challenges and opportunities.华法林的药物遗传学:挑战与机遇。
J Hum Genet. 2013 Jun;58(6):334-8. doi: 10.1038/jhg.2013.40. Epub 2013 May 9.
3
Analysis of Clinical Record Data for Anticoagulation Management within an EHR System.电子健康记录(EHR)系统中抗凝管理的临床记录数据分析
Open Med Inform J. 2009 Aug 19;3:54-64. doi: 10.2174/1874431100903010054.
4
External quality assessment for warfarin dosing using computerised decision support software.使用计算机决策支持软件对华法林剂量进行外部质量评估。
J Clin Pathol. 2003 Aug;56(8):605-7. doi: 10.1136/jcp.56.8.605.
5
Fortnightly review: anticoagulation in heart disease.双周综述:心脏病中的抗凝治疗
BMJ. 1999 Jan 23;318(7178):238-44. doi: 10.1136/bmj.318.7178.238.